These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33573068)

  • 1. Salivary Immunoglobulin Gamma-3 Chain C Is a Promising Noninvasive Biomarker for Systemic Lupus Erythematosus.
    Jung JY; Nam JY; Ryu KS; Son IO; Shin JH; Baek WY; Kim HA; Suh CH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus.
    Jung JY; Kim JW; Lee SW; Baek WY; Kim HA; Suh CH
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus.
    Kim JW; Jung JY; Lee SW; Baek WY; Kim HA; Suh CH
    Front Immunol; 2022; 13():886209. PubMed ID: 35529863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole saliva in systemic lupus erythematosus patients.
    Ben-Aryeh H; Gordon N; Szargel R; Toubi E; Laufer D
    Oral Surg Oral Med Oral Pathol; 1993 Jun; 75(6):696-9. PubMed ID: 7685874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus.
    Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH
    J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
    Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
    Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary biomarkers of inflammation in systemic lupus erythematosus.
    Stanescu II; Calenic B; Dima A; Gugoasa LA; Balanescu E; Stefan-van Staden RI; Baicus C; Badita DG; Greabu M
    Ann Anat; 2018 Sep; 219():89-93. PubMed ID: 29621567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
    Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
    Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ananti-alpha-actinin test completes ananti-DNA determination in systemic lupus erythematosus.
    Croquefer S; Renaudineau Y; Jousse S; Gueguen P; Ansart S; Saraux A; Youinou P
    Ann N Y Acad Sci; 2005 Jun; 1050():170-5. PubMed ID: 16014531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
    Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study Group.
    Witte T; Hartung K; Matthias T; Sachse C; Fricke M; Deicher H; Kalden JR; Lakomek HJ; Peter HH; Schmidt RE
    Rheumatol Int; 1998; 18(2):63-9. PubMed ID: 9782535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus.
    Romero-Ramírez S; Sosa-Hernández VA; Cervantes-Díaz R; Carrillo-Vázquez DA; Meza-Sánchez DE; Núñez-Álvarez C; Torres-Ruiz J; Gómez-Martín D; Maravillas-Montero JL
    Front Immunol; 2023; 14():1080154. PubMed ID: 36911711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary proteomics: A new adjuvant approach to the early diagnosis of familial juvenile systemic lupus erythematosus.
    Abrão AL; Falcao DP; de Amorim RF; Bezerra AC; Pombeiro GA; Guimarães LJ; Fregni F; Silva LP; da Mota LM
    Med Hypotheses; 2016 Apr; 89():97-100. PubMed ID: 26968919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects.
    Wu Y; Shu R; Luo LJ; Ge LH; Xie YF
    J Periodontal Res; 2009 Oct; 44(5):636-44. PubMed ID: 19453860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.
    Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M
    Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.